Status:
UNKNOWN
Premature Atherosclerosis in Systemic Lupus Erythematosus
Lead Sponsor:
Peking Union Medical College Hospital
Collaborating Sponsors:
Beijing Municipal Science & Technology Commission
National Natural Science Foundation of China
Conditions:
SLE
Atherosclerosis
Eligibility:
All Genders
18+ years
Brief Summary
Patients with SLE have increased rates of atherosclerosis, while the risk factors for atherosclerosis in those patients were not fully revealed. This study is an observational study to investigate the...
Detailed Description
Accelerated atherosclerosis is a major complication of systemic lupus erythematosus (SLE), and it leads to increased cardiovascular morbidity and mortality in patients with SLE. Prevention and interve...
Eligibility Criteria
Inclusion
- Age≥18 years
- Fulfillment of clinical classification criteria of SLE (four or more 1997 American College of Rheumatology classification criteria)
- Provision of signed written informed consent
Exclusion
- Clinically overt coronary artery disease
- A history of cardiovascular disease (previous stroke, heart failure, myocardial infarction, angina, or symptomatic PAD)
- Malignancy
- Pregnant/lactating women
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2021
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04037293
Start Date
May 1 2013
End Date
December 1 2021
Last Update
July 31 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hostipal
Beijing, Beijing Municipality, China, 100010